Strategy for prevention of cancers of the esophagus

摘要

The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase Ⅱ trials in Barrett's adenocarcinoma; statins in chemo-prevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.